Key result
Selective serotonin re-uptake inhibitors (SSRIs) were associated with a significantly longer seizure duration during electroconvulsive therapy compared with TCAs and MAOIs.
Why the study?
Do selective serotonin re-uptake inhibitors (SSRIs) prolong seizure duration in patients undergoing electroconvulsive therapy (ECT)?
Observational
Do selective serotonin re-uptake inhibitors (SSRIs) prolong seizure duration in patients undergoing electroconvulsive therapy (ECT)?
SSRIs may significantly prolong seizure duration during ECT compared to TCAs and MAOIs, though the clinical impact remains unclear.
Answers are grounded in this paper and cite their sources.
SSRIs may prolong ECT seizure duration; hypothesis-generating observation needing prospective confirmation.
The effect of selective serotonin re-uptake inhibitors (SSRIs) on seizure duration during a course of electroconvulsive therapy (ECT) was evaluated in a retrospective study. Although numbers in the SSRI group were small (n=13), there was a significantly longer seizure duration with SSRIs, compared with tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). More studies are needed to see whether this is a general finding or whether it reflects individual variation, and most importantly, what effects, if any, this has on clinical outcome.
No takes yet. Share an insight, caveat, or question.
Potokar et al. (1997) conducted an observational in Patients undergoing electroconvulsive therapy (ECT). Selective serotonin re-uptake inhibitors (SSRIs) vs. Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) was evaluated on Seizure duration. Selective serotonin re-uptake inhibitors (SSRIs) were associated with a significantly longer seizure duration during electroconvulsive therapy compared with TCAs and MAOIs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: